posted on 01/04/2021 06:00
(credit: Cleia Viana / Chamber of Deputies)
Congress should discuss proposals to relax the legislation, passed in early March and already signed by President Jair Bolsonaro, who authorized the purchase of vaccines against covid-19 by states, municipalities and the private sector. Under pressure from businessmen, parliamentarians are thinking of changing the wording of the text to allow companies to, in addition to purchasing immunizers, immediately use half the doses on their employees and, if they wish, donate the rest to the Unified Health System (SUS) .
Under current legislation, the private sector can buy drugs, but must deliver to the federal government 100% of the doses acquired while the National Immunization Plan (PNI) has not served all those who make up the priority groups for vaccination against the new coronavirus . Only after this stage will companies be able to retain 50% of the doses to give to employees free of charge.
Yesterday, at the first meeting of the crisis committee created by Bolsonaro to monitor the Executive’s actions against the covid-19, the presidents of the Chamber, Arthur Lira (PP-AL), and the Senate, Rodrigo Pacheco (DEM-MG), they signaled to the Chief Executive that it is necessary to increase the participation of the private sector in the purchase of immunizers so that vaccination coverage is expanded and the economy returns to normal.
“Any vaccinated Brazilian is one less in the statistics of contracting the virus. The Chamber is attentive and available so that the legislative measures can help to have more agility ”, said Lira.
The topic was also dealt with at the Chamber of Leaders of the Chamber. Parliamentarians called for “urgent urgency” in analyzing the text, which is due to be voted on next week. The proposal is contained in a report by Congresswoman Celina Leão (Progressistas-DF), which suggests that, in addition to applying vaccines to their employees, companies can choose between attending the employees’ first-degree relatives or sending the remaining doses to SUS.
Get the latest news delivered to your inbox
Follow us on social media networks